Skip to main content
Erschienen in: Medical Oncology 9/2019

01.09.2019 | Original Paper

Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series

verfasst von: John M. Kennedy, Xiaoming Wang, Komal R. Plouffe, Saravana M. Dhanasekaran, Khaled Hafez, Ganesh S. Palapattu, Tobias Else, Alon Z. Weizer, Todd M. Morgan, Daniel E. Spratt, Matthew S. Davenport, Arul M. Chinnaiyan, Aaron M. Udager, Rohit Mehra

Erschienen in: Medical Oncology | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

Hereditary renal cell carcinoma syndromes (HRCCS) are characterized by the presence of pathogenic germline variants that predispose patients to renal cell carcinomas as well as additional extra-renal manifestations. The importance of identifying HRCCS patients cannot be overemphasized, as patients and their families can begin surveillance for syndrome-associated manifestations once identified. The present study is a retrospective clinical and morphologic review of 60 hereditary renal tumors from 30 HRCCS patients treated at our institution with either Von Hippel-Lindau disease (VHL), Birt-Hogg-Dubé syndrome (BHD), tuberous sclerosis complex (TSC), hereditary leiomyomatosis and renal cell cancer syndrome, or succinate dehydrogenase (SDH) deficiency syndrome. Hereditary renal cell carcinoma syndromes kidney tumors often demonstrate specific morphologic features, characteristic background changes in renal parenchyma, and extra-renal manifestations, which, when recognized by the pathologist, can trigger genetic testing referral for specific familial cancer syndromes. Our study demonstrates the majority of tumors were consistent with the anticipated clinicopathologic profile of renal tumors found within HRCCS patients, although we found some unique characteristics within this cohort including a case of clear cell papillary renal cell carcinoma within a VHL patient, and a unique renal tumor with tubulopapillary features present in a patient with a germline SDHD mutation. Additionally, although the literature reports the presence of epithelioid angiomyolipoma (AML) as a common occurrence in TSC patients, our cohort of 3 patients with AMLs demonstrated only classic features. The findings we describe facilitate pathologist-based recognition of HRCCS and can prompt genetic evaluation for relevant patients.
Literatur
1.
Zurück zum Zitat Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2018;68:394–424.PubMed Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2018;68:394–424.PubMed
2.
Zurück zum Zitat Adeniran AJ, Shuch B, Humphrey PA. Hereditary renal cell carcinoma syndromes: clinical, pathologic, and genetic features. Am J Surg Pathol. 2015;39:e1–18.CrossRef Adeniran AJ, Shuch B, Humphrey PA. Hereditary renal cell carcinoma syndromes: clinical, pathologic, and genetic features. Am J Surg Pathol. 2015;39:e1–18.CrossRef
3.
Zurück zum Zitat Barrisford GW, Singer EA, Rosner IL, et al. Familial renal cancer: molecular genetics and surgical management. Int J Surg Oncol. 2011;2011:658767.PubMedPubMedCentral Barrisford GW, Singer EA, Rosner IL, et al. Familial renal cancer: molecular genetics and surgical management. Int J Surg Oncol. 2011;2011:658767.PubMedPubMedCentral
4.
Zurück zum Zitat Gaur S, Turkbey B, Choyke P. Hereditary renal tumor syndromes: update on diagnosis and management. Semin Ultrasound CT MR. 2017;38:59–71.CrossRef Gaur S, Turkbey B, Choyke P. Hereditary renal tumor syndromes: update on diagnosis and management. Semin Ultrasound CT MR. 2017;38:59–71.CrossRef
5.
Zurück zum Zitat Menko FH, Maher ER. Diagnosis and management of hereditary renal cell cancer. Recent Results Cancer Res. 2016;205:85–104.CrossRef Menko FH, Maher ER. Diagnosis and management of hereditary renal cell cancer. Recent Results Cancer Res. 2016;205:85–104.CrossRef
6.
Zurück zum Zitat Coleman JA, Russo P. Hereditary and familial kidney cancer. Curr Opin Urol. 2009;19:478–85.CrossRef Coleman JA, Russo P. Hereditary and familial kidney cancer. Curr Opin Urol. 2009;19:478–85.CrossRef
7.
Zurück zum Zitat Maher ER. Genetics of familial renal cancers. Nephron Exp Nephrol. 2011;118:e21–6.CrossRef Maher ER. Genetics of familial renal cancers. Nephron Exp Nephrol. 2011;118:e21–6.CrossRef
8.
Zurück zum Zitat Sampson JR, Yates JR, Pirrit LA, et al. Evidence for genetic heterogeneity in tuberous sclerosis. J Med Genet. 1989;26:511–6.CrossRef Sampson JR, Yates JR, Pirrit LA, et al. Evidence for genetic heterogeneity in tuberous sclerosis. J Med Genet. 1989;26:511–6.CrossRef
9.
Zurück zum Zitat Przybycin CG, Magi-Galluzzi C, McKenney JK. Hereditary syndromes with associated renal neoplasia: a practical guide to histologic recognition in renal tumor resection specimens. Adv Anat Pathol. 2013;20:245–63.CrossRef Przybycin CG, Magi-Galluzzi C, McKenney JK. Hereditary syndromes with associated renal neoplasia: a practical guide to histologic recognition in renal tumor resection specimens. Adv Anat Pathol. 2013;20:245–63.CrossRef
10.
Zurück zum Zitat Moch HP, Humphrey PA, Ulbright TM, Reuter VE. WHO classification of tumors of the urinary system and male genital organs. 4th ed. Lyon: IARC; 2016. Moch HP, Humphrey PA, Ulbright TM, Reuter VE. WHO classification of tumors of the urinary system and male genital organs. 4th ed. Lyon: IARC; 2016.
11.
Zurück zum Zitat Crespigio J, Berbel LCL, Dias MA, et al. Von Hippel-Lindau disease: a single gene, several hereditary tumors. J Endocrinol Invest. 2018;41:21–31.CrossRef Crespigio J, Berbel LCL, Dias MA, et al. Von Hippel-Lindau disease: a single gene, several hereditary tumors. J Endocrinol Invest. 2018;41:21–31.CrossRef
12.
Zurück zum Zitat Menko FH, van Steensel MA, Giraud S, et al. Birt-Hogg-Dube syndrome: diagnosis and management. Lancet Oncol. 2009;10:1199–206.CrossRef Menko FH, van Steensel MA, Giraud S, et al. Birt-Hogg-Dube syndrome: diagnosis and management. Lancet Oncol. 2009;10:1199–206.CrossRef
13.
Zurück zum Zitat Northrup H, Krueger DA. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 iinternational tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013;49:243–54.CrossRef Northrup H, Krueger DA. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 iinternational tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013;49:243–54.CrossRef
14.
Zurück zum Zitat Menko FH, Maher ER, Schmidt LS, et al. Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment. Fam Cancer. 2014;13:637–44.CrossRef Menko FH, Maher ER, Schmidt LS, et al. Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment. Fam Cancer. 2014;13:637–44.CrossRef
15.
Zurück zum Zitat Hovelson DH, McDaniel AS, Cani AK, et al. Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors. Neoplasia. 2015;17:385–99.CrossRef Hovelson DH, McDaniel AS, Cani AK, et al. Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors. Neoplasia. 2015;17:385–99.CrossRef
16.
Zurück zum Zitat Wang L, Zhang Y, Chen YB, et al. VSTM2A overexpression is a sensitive and specific biomarker for mucinous tubular and spindle cell carcinoma (MTSCC) of the Kidney. Am J Surg Pathol. 2018;42:1571–84.CrossRef Wang L, Zhang Y, Chen YB, et al. VSTM2A overexpression is a sensitive and specific biomarker for mucinous tubular and spindle cell carcinoma (MTSCC) of the Kidney. Am J Surg Pathol. 2018;42:1571–84.CrossRef
17.
Zurück zum Zitat Varshney N, Kebede AA, Owusu-Dapaah H, et al. A Review of Von Hippel-Lindau Syndrome. J Kidney Cancer VHL. 2017;4:20–9.CrossRef Varshney N, Kebede AA, Owusu-Dapaah H, et al. A Review of Von Hippel-Lindau Syndrome. J Kidney Cancer VHL. 2017;4:20–9.CrossRef
18.
Zurück zum Zitat Ashouri K, Mohseni S, Tourtelot J, et al. Implications of Von Hippel-Lindau syndrome and renal cell carcinoma. J Kidney Cancer VHL. 2015;2:163–73.CrossRef Ashouri K, Mohseni S, Tourtelot J, et al. Implications of Von Hippel-Lindau syndrome and renal cell carcinoma. J Kidney Cancer VHL. 2015;2:163–73.CrossRef
19.
Zurück zum Zitat Lonser RR, Glenn GM, Walther M, et al. von Hippel-Lindau disease. Lancet. 2003;361:2059–67.CrossRef Lonser RR, Glenn GM, Walther M, et al. von Hippel-Lindau disease. Lancet. 2003;361:2059–67.CrossRef
20.
Zurück zum Zitat Nielsen SM, Rhodes L, Blanco I, et al. Von Hippel-Lindau disease: genetics and role of genetic counseling in a multiple neoplasia syndrome. J Clin Oncol. 2016;34:2172–81.CrossRef Nielsen SM, Rhodes L, Blanco I, et al. Von Hippel-Lindau disease: genetics and role of genetic counseling in a multiple neoplasia syndrome. J Clin Oncol. 2016;34:2172–81.CrossRef
21.
Zurück zum Zitat Kawashima A, Young SW, Takahashi N, et al. Inherited renal carcinomas. Abdom Radiol. 2016;41:1066–78.CrossRef Kawashima A, Young SW, Takahashi N, et al. Inherited renal carcinomas. Abdom Radiol. 2016;41:1066–78.CrossRef
22.
Zurück zum Zitat Walther MM, Lubensky IA, Venzon D, et al. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. J Urol. 1995;154:2010–4. discussion 2014–15.CrossRef Walther MM, Lubensky IA, Venzon D, et al. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. J Urol. 1995;154:2010–4. discussion 2014–15.CrossRef
23.
Zurück zum Zitat Chen YB, Tickoo SK. Spectrum of preneoplastic and neoplastic cystic lesions of the kidney. Arch Pathol Lab Med. 2012;136:400–9.CrossRef Chen YB, Tickoo SK. Spectrum of preneoplastic and neoplastic cystic lesions of the kidney. Arch Pathol Lab Med. 2012;136:400–9.CrossRef
24.
Zurück zum Zitat Montani M, Heinimann K, von Teichman A, et al. VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease. Am J Surg Pathol. 2010;34:806–15.CrossRef Montani M, Heinimann K, von Teichman A, et al. VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease. Am J Surg Pathol. 2010;34:806–15.CrossRef
25.
Zurück zum Zitat Phillips JL, Ghadimi BM, Wangsa D, et al. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease. Genes Chromosom Cancer. 2001;31:1–9.CrossRef Phillips JL, Ghadimi BM, Wangsa D, et al. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease. Genes Chromosom Cancer. 2001;31:1–9.CrossRef
26.
Zurück zum Zitat Matoso A, Chen YB, Rao V, et al. Atypical renal cysts: a morphologic, immunohistochemical, and molecular study. Am J Surg Pathol. 2016;40:202–11.PubMed Matoso A, Chen YB, Rao V, et al. Atypical renal cysts: a morphologic, immunohistochemical, and molecular study. Am J Surg Pathol. 2016;40:202–11.PubMed
27.
Zurück zum Zitat Tickoo SK, dePeralta-Venturina MN, Harik LR, et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol. 2006;30:141–53.CrossRef Tickoo SK, dePeralta-Venturina MN, Harik LR, et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol. 2006;30:141–53.CrossRef
28.
Zurück zum Zitat Rohan SM, Xiao Y, Liang Y, et al. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. Mod Pathol. 2011;24:1207–20.CrossRef Rohan SM, Xiao Y, Liang Y, et al. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. Mod Pathol. 2011;24:1207–20.CrossRef
29.
Zurück zum Zitat Williamson SR, Eble JN, Cheng L, et al. Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile. Mod Pathol. 2013;26:697–708.CrossRef Williamson SR, Eble JN, Cheng L, et al. Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile. Mod Pathol. 2013;26:697–708.CrossRef
30.
Zurück zum Zitat Diolombi ML, Cheng L, Argani P, et al. Do clear cell papillary renal cell carcinomas have malignant potential? Am J Surg Pathol. 2015;39:1621–34.CrossRef Diolombi ML, Cheng L, Argani P, et al. Do clear cell papillary renal cell carcinomas have malignant potential? Am J Surg Pathol. 2015;39:1621–34.CrossRef
31.
Zurück zum Zitat Rao P, Monzon F, Jonasch E, et al. Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome–clinicopathological features and comparative genomic analysis of 3 cases. Hum Pathol. 2014;45:1966–72.CrossRef Rao P, Monzon F, Jonasch E, et al. Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome–clinicopathological features and comparative genomic analysis of 3 cases. Hum Pathol. 2014;45:1966–72.CrossRef
32.
Zurück zum Zitat Williamson SR, Zhang S, Eble JN, et al. Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma. Am J Surg Pathol. 2013;37:1131–9.CrossRef Williamson SR, Zhang S, Eble JN, et al. Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma. Am J Surg Pathol. 2013;37:1131–9.CrossRef
33.
Zurück zum Zitat Toro JR, Wei MH, Glenn GM, et al. BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: a new series of 50 families and a review of published reports. J Med Genet. 2008;45:321–31.CrossRef Toro JR, Wei MH, Glenn GM, et al. BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: a new series of 50 families and a review of published reports. J Med Genet. 2008;45:321–31.CrossRef
34.
Zurück zum Zitat Benusiglio PR, Giraud S, Deveaux S, et al. Renal cell tumour characteristics in patients with the Birt-Hogg-Dube cancer susceptibility syndrome: a retrospective, multicentre study. Orphanet J Rare Dis. 2014;9:163.CrossRef Benusiglio PR, Giraud S, Deveaux S, et al. Renal cell tumour characteristics in patients with the Birt-Hogg-Dube cancer susceptibility syndrome: a retrospective, multicentre study. Orphanet J Rare Dis. 2014;9:163.CrossRef
35.
Zurück zum Zitat Zbar B, Alvord WG, Glenn G, et al. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome. Cancer Epidemiol Biomark Prev. 2002;11:393–400. Zbar B, Alvord WG, Glenn G, et al. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome. Cancer Epidemiol Biomark Prev. 2002;11:393–400.
36.
Zurück zum Zitat Pavlovich CP, Walther MM, Eyler RA, et al. Renal tumors in the Birt-Hogg-Dube syndrome. Am J Surg Pathol. 2002;26:1542–52.CrossRef Pavlovich CP, Walther MM, Eyler RA, et al. Renal tumors in the Birt-Hogg-Dube syndrome. Am J Surg Pathol. 2002;26:1542–52.CrossRef
37.
Zurück zum Zitat Tickoo SK, Reuter VE, Amin MB, et al. Renal oncocytosis: a morphologic study of fourteen cases. Am J Surg Pathol. 1999;23:1094–101.CrossRef Tickoo SK, Reuter VE, Amin MB, et al. Renal oncocytosis: a morphologic study of fourteen cases. Am J Surg Pathol. 1999;23:1094–101.CrossRef
38.
Zurück zum Zitat Gobbo S, Eble JN, Delahunt B, et al. Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profiles. Am J Surg Pathol. 2010;34:620–6.PubMed Gobbo S, Eble JN, Delahunt B, et al. Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profiles. Am J Surg Pathol. 2010;34:620–6.PubMed
39.
Zurück zum Zitat Chung JY, Ramos-Caro FA, Beers B, et al. Multiple lipomas, angiolipomas, and parathyroid adenomas in a patient with Birt-Hogg-Dube syndrome. Int J Dermatol. 1996;35:365–7.CrossRef Chung JY, Ramos-Caro FA, Beers B, et al. Multiple lipomas, angiolipomas, and parathyroid adenomas in a patient with Birt-Hogg-Dube syndrome. Int J Dermatol. 1996;35:365–7.CrossRef
40.
Zurück zum Zitat Rakowski SK, Winterkorn EB, Paul E, et al. Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int. 2006;70:1777–82.CrossRef Rakowski SK, Winterkorn EB, Paul E, et al. Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int. 2006;70:1777–82.CrossRef
41.
Zurück zum Zitat Yang P, Cornejo KM, Sadow PM, et al. Renal cell carcinoma in tuberous sclerosis complex. Am J Surg Pathol. 2014;38:895–909.CrossRef Yang P, Cornejo KM, Sadow PM, et al. Renal cell carcinoma in tuberous sclerosis complex. Am J Surg Pathol. 2014;38:895–909.CrossRef
42.
Zurück zum Zitat Tello R, Blickman JG, Buonomo C, et al. Meta analysis of the relationship between tuberous sclerosis complex and renal cell carcinoma. Eur J Radiol. 1998;27:131–8.CrossRef Tello R, Blickman JG, Buonomo C, et al. Meta analysis of the relationship between tuberous sclerosis complex and renal cell carcinoma. Eur J Radiol. 1998;27:131–8.CrossRef
43.
Zurück zum Zitat Guo J, Tretiakova MS, Troxell ML, et al. Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients. Am J Surg Pathol. 2014;38:1457–67.CrossRef Guo J, Tretiakova MS, Troxell ML, et al. Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients. Am J Surg Pathol. 2014;38:1457–67.CrossRef
44.
Zurück zum Zitat Aydin H, Magi-Galluzzi C, Lane BR, et al. Renal angiomyolipoma: clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association. Am J Surg Pathol. 2009;33:289–97.CrossRef Aydin H, Magi-Galluzzi C, Lane BR, et al. Renal angiomyolipoma: clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association. Am J Surg Pathol. 2009;33:289–97.CrossRef
45.
Zurück zum Zitat Jimenez RE, Eble JN, Reuter VE, et al. Concurrent angiomyolipoma and renal cell neoplasia: a study of 36 cases. Mod Path. 2001;14:157–63.CrossRef Jimenez RE, Eble JN, Reuter VE, et al. Concurrent angiomyolipoma and renal cell neoplasia: a study of 36 cases. Mod Path. 2001;14:157–63.CrossRef
46.
Zurück zum Zitat He W, Cheville JC, Sadow PM, et al. Epithelioid angiomyolipoma of the kidney: pathological features and clinical outcome in a series of consecutively resected tumors. Mod Pathol. 2013;26:1355–64.CrossRef He W, Cheville JC, Sadow PM, et al. Epithelioid angiomyolipoma of the kidney: pathological features and clinical outcome in a series of consecutively resected tumors. Mod Pathol. 2013;26:1355–64.CrossRef
47.
Zurück zum Zitat Nese N, Martignoni G, Fletcher CD, et al. Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: a clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification. Am J Surg Pathol. 2011;35:161–76.CrossRef Nese N, Martignoni G, Fletcher CD, et al. Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: a clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification. Am J Surg Pathol. 2011;35:161–76.CrossRef
48.
Zurück zum Zitat Brimo F, Robinson B, Guo C, et al. Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy. Am J Surg Pathol. 2010;34:715–22.PubMed Brimo F, Robinson B, Guo C, et al. Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy. Am J Surg Pathol. 2010;34:715–22.PubMed
49.
Zurück zum Zitat Schreiner A, Daneshmand S, Bayne A, et al. Distinctive morphology of renal cell carcinomas in tuberous sclerosis. Int J Surg Pathol. 2010;18:409–18.CrossRef Schreiner A, Daneshmand S, Bayne A, et al. Distinctive morphology of renal cell carcinomas in tuberous sclerosis. Int J Surg Pathol. 2010;18:409–18.CrossRef
50.
Zurück zum Zitat Kopp RP, Stratton KL, Glogowski E, et al. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma. Cancer. 2017;123:2452–8.CrossRef Kopp RP, Stratton KL, Glogowski E, et al. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma. Cancer. 2017;123:2452–8.CrossRef
51.
Zurück zum Zitat Launonen V, Vierimaa O, Kiuru M, et al. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA. 2001;98:3387–92.CrossRef Launonen V, Vierimaa O, Kiuru M, et al. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA. 2001;98:3387–92.CrossRef
52.
Zurück zum Zitat Merino MJ, Torres-Cabala C, Pinto P, et al. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol. 2007;31:1578–85.CrossRef Merino MJ, Torres-Cabala C, Pinto P, et al. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol. 2007;31:1578–85.CrossRef
53.
Zurück zum Zitat Trpkov K, Hes O, Agaimy A, et al. Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome. Am J Surg Pathol. 2016;40:865–75.CrossRef Trpkov K, Hes O, Agaimy A, et al. Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome. Am J Surg Pathol. 2016;40:865–75.CrossRef
54.
Zurück zum Zitat Gill AJ, Hes O, Papathomas T, et al. Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients. Am J Surg Pathol. 2014;38:1588–602.CrossRef Gill AJ, Hes O, Papathomas T, et al. Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients. Am J Surg Pathol. 2014;38:1588–602.CrossRef
55.
Zurück zum Zitat Andrews KA, Ascher DB, Pires DEV, et al. Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD. J Med Genet. 2018;55:384–94.PubMed Andrews KA, Ascher DB, Pires DEV, et al. Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD. J Med Genet. 2018;55:384–94.PubMed
56.
Zurück zum Zitat Williamson SR, Eble JN, Amin MB, et al. Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma. Mod Pathol. 2015;28:80–94.CrossRef Williamson SR, Eble JN, Amin MB, et al. Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma. Mod Pathol. 2015;28:80–94.CrossRef
57.
Zurück zum Zitat Gill AJ, Pachter NS, Chou A, et al. Renal tumors associated with germline SDHB mutation show distinctive morphology. Am J Surg Pathol. 2011;35:1578–85.CrossRef Gill AJ, Pachter NS, Chou A, et al. Renal tumors associated with germline SDHB mutation show distinctive morphology. Am J Surg Pathol. 2011;35:1578–85.CrossRef
58.
Zurück zum Zitat Ricketts CJ, Shuch B, Vocke CD, et al. Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol. 2012;188:2063–71.CrossRef Ricketts CJ, Shuch B, Vocke CD, et al. Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol. 2012;188:2063–71.CrossRef
59.
Zurück zum Zitat Linehan WM, Pinto PA, Bratslavsky G, et al. Hereditary kidney cancer: unique opportunity for disease-based therapy. Cancer. 2009;115:2252–61.CrossRef Linehan WM, Pinto PA, Bratslavsky G, et al. Hereditary kidney cancer: unique opportunity for disease-based therapy. Cancer. 2009;115:2252–61.CrossRef
Metadaten
Titel
Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series
verfasst von
John M. Kennedy
Xiaoming Wang
Komal R. Plouffe
Saravana M. Dhanasekaran
Khaled Hafez
Ganesh S. Palapattu
Tobias Else
Alon Z. Weizer
Todd M. Morgan
Daniel E. Spratt
Matthew S. Davenport
Arul M. Chinnaiyan
Aaron M. Udager
Rohit Mehra
Publikationsdatum
01.09.2019
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 9/2019
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-019-1297-6

Weitere Artikel der Ausgabe 9/2019

Medical Oncology 9/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.